Mezigdomide Expanded Access

Expanded Access for Mezigdomide

  • 202123

More Information

Trial Status
Accepting patients
Trial Phase
Expanded Access
Sponsors
Bristol Myers Squibb
Tags
Cereblon E3 Ligase Modulators (CELMoDs)
Trial Type
Expanded Access / Compassionate Use
Last Update
SparkCures ID
2136
NCT Identifier
NCT06994117

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 864-8426

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.